Multidose formulation of ready-to-use 177Lu-PSMA-617 in a centralized radiopharmacy set-up
Author:
Funder
Department of Atomic Energy, India
Publisher
Elsevier BV
Subject
Radiation
Reference14 articles.
1. Early side effects and first results of radio-ligand therapy with 177Lu-DKFZ-617 PSMA of castrate-resistant metastatic prostate cancer: a two-centre study;Ahmadzadehfar;EJNMMI Res.,2015
2. Therapeutic response and side effects of repeated radioligand therapy with 177Lu-PSMA-DKFZ-617 of castration-resistant metastatic prostate cancer;Ahmadzadehfar;Oncotarget,2016
3. Comprehensive quality control of the ITG Ge-68/Ga-68 generator and synthesis of Ga-68-DOTATOC and Ga-68-PSMA-HBED-CC for clinical imaging;Amor-Coarasa;J. Nucl. Med.,2016
4. Precinical evaluation of tailor-made DOTA-conjugated PSMA inhibitor with optimized linker moiety for imaging and endoradiotherapy of prostate cancer;Benesova;J. Nucl. Med.,2015
5. 177Lu-PSMA-617 radioligand therapy and outcome in patients with metastasized castration-resistant prostate cancer;Brauer;Eur. J. Nucl. Med. Mol. Imaging,2017
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A third generation PSMA-targeted agent [211At]YF2: Synthesis and in vivo evaluation;Nuclear Medicine and Biology;2024-07
2. Selection and Use of Antioxidants-radioprotectors in the Composition of Therapeutic Radiopharmaceuticals (Review);Drug development & registration;2023-09-26
3. Radiolysis-Associated Decrease in Radiochemical Purity of 177Lu-Radiopharmaceuticals and Comparison of the Effectiveness of Selected Quenchers against This Process;Molecules;2023-02-16
4. Fate of 177Lu-CHX-A”-DTPA-Rituximab: In vitro Evaluation in Raji Cell Line;Journal of Radiation and Cancer Research;2023
5. Features and Practical Aspects of Radiochemical Purity Determination of Receptor-Specific Lu-177 Radiopharmaceuticals as Exemplified by [<sup>177</sup>Lu]Lu–PSMA-617;The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products. Regulatory Research and Medicine Evaluation;2022-11-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3